# BlossomHill Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/blossomhill-therapeutics

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.bhtherapeutics.com
- Total disclosed funding: $244M
- Latest round: Series B (Nov 25, 2025)
- Investors on record: 10

## About

Founded in 2020 and based in California, US, BlossomHill Therapeutics, Inc. operates as a molecule drug discovery and development company. The company was co-founded by President and CEO Dr. J. Jean Cui and Dr. Y. Peter Li. In December 2025, BlossomHill Therapeutics, Inc. raised USD 84 million in series B funding co-led by Janus Henderson Investors, BioTrack Capital and Brahma Capital, with participation from Cormorant Asset Management, OrbiMed Advisors, Vivo Capital, and Plaisance Capital Management LLC. 

BlossomHill Therapeutics is a small molecule drug discovery and development company focused on unmet medical needs in oncology, identifying key clinical needs, and discovering autoimmune disorders.

The company plans to use the December 2025 funding to continue clinical testing of its main cancer drug candidates and to support development of its other oncology programs.

## Funding rounds

- Series B, Nov 25, 2025, $84M — OrbiMed Advisors, Vivo Capital, Janus Henderson Investors, Cormorant Asset Management, BioTrack Capital, Brahma Capital
- Series B, Dec 28, 2023, $89M — OrbiMed Advisors, Colt Ventures, Vivo Capital, Plaisance Capital, Cormorant Asset Management, Hercules Bioventures, H&D Asset Management
- Series A, Mar 1, 2021, $71M — OrbiMed Advisors, Vivo Capital, Cormorant Asset Management, Hercules Bioventures

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A, Series B
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series A, Series B
- Hercules Bioventures — Series A, Series B
- Colt Ventures (https://capitalatlas.ai/funds/colt-ventures) — Series B
- Plaisance Capital — Series B
- H&D Asset Management (https://capitalatlas.ai/funds/h-d-asset-management) — Series B
- Janus Henderson Investors — Series B
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series B
- Brahma Capital — Series B